SectorPharmaceutical
Established Date19/02/2015
Listing Date21/06/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees9
Fiscal Year Ends31/12
Security TypeCommon stock
Office address4000 Shoreline Court, Suite 300, South San Francisco, CA 94080
Business
IntroductionKezar Life Sciences, Inc., was incorporated under the laws of the State of Delaware on February 19, 2015. The company is a clinical-stage biotechnology company developing novel small molecule therapies for the treatment of unmet needs in immune-mediated diseases and cancer. The company is advancing two drug development programs that utilize different regulators of cell function: the first targets the immunoproteasome, which is responsible for many key aspects of protein degradation in immune system cells and drives immune cell function, and the second targets the Sec61 transposon.
